Tin tức & Cập nhật
Xem bài viết Tiêu hóa
Xem
Chỉ hiển thị Multimedia

Seladelpar improves liver outcomes in cirrhosis patients with PBC, portal hypertension
2 giờ trước
bởiStephen Padilla
Treatment with seladelpar for 4 years yields consistent biochemical efficacy, with no new safety concerns, among patients with cirrhosis and primary biliary cholangitis (PBC), as shown by interim results from the open-label ASSURE study.
Seladelpar improves liver outcomes in cirrhosis patients with PBC, portal hypertension
2 giờ trước
Heavy alcohol consumption raises CRC risk
10 Jun 2026
bởiStephen Padilla
Individuals with high alcohol consumption are at increased risk of colorectal cancer (CRC), reports a study, which shows that alcohol intake may trigger colorectal carcinogenesis through mechanisms operating across major molecular pathways for CRC.
Heavy alcohol consumption raises CRC risk
10 Jun 2026
Daraxonrasib makes history in one of the deadliest cancers
09 Jun 2026
bởiAudrey Abella
Daraxonrasib—an oral, potent RAS(ON) multi-selective, tri-complex inhibitor—demonstrates unprecedented survival benefits in individuals with previously treated metastatic pancreatic adenocarcinoma (mPDAC) in the landmark phase III RASolute 302 study.






